This poster describes the evaluation of an in vitro human iPSC-derived blood-brain barrier (BBB) model to assess the BBB permeability of small molecules, therapeutic monoclonal antibodies, and antisense oligonucleotides.
Authors: Malika Bsibsi1, Lianne van Beek1, Cindy J.M. Loomans1, Ludovico Buti1, Timur Yavezturk1, Narendra Chunduri1, Fatma Masmoudi1, Rebecca Beaumont2 and Anne-Marie Zuurmond1.
1: IQVIA Laboratories, Leiden, Netherlands
2: IQVIA Laboratories, Cambridge, UK
Download Document
